✦ LIBER ✦

Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting

✍ Scribed by Navarro, R.; Vilarrasa, E.; Herranz, P.; Puig, L.; Bordas, X.; Carrascosa, J.M.; Taberner, R.; Ferrán, M.; García-Bustinduy, M.; Romero-Maté, A.; Pedragosa, R.; García-Diez, A.; Daudén, E.

Book ID: 120079685
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 93 KB
Volume: 168
Category: Article
ISSN: 0007-0963
DOI: 10.1111/bjd.12045

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumour necrosis factor-α antagonists in

Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients

✍ F. Prignano; F. Ricceri; L. Pescitelli; F. Zanieri; T. Lotti 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Safety of antitumour necrosis factor-α t

Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection

✍ L. Nosotti; F. Francesconi; S. Izzi; E. Berardesca; A. Morrone; C. Bonifati 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Anti–tumour necrosis factor-α therapy in

Anti–tumour necrosis factor-α therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study

✍ P Gisondi; C Cotena; G Tessari; G Girolomoni 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Safety of anti-tumour necrosis factor-α

Safety of anti-tumour necrosis factor-α agents in psoriasis patients who were chronic hepatitis B carriers: a retrospective report of seven patients and brief review of the literature

✍ C Fotiadou; E Lazaridou; D Ioannides 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Hepatotoxicity and effectiveness of a Ne

Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon

✍ Jules B Tchatchueng Mbougua; Christian Laurent; Charles Kouanfack; Anke Bourgeoi 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 312 KB

T-9 2-year effectiveness and safety of t

T-9 2-year effectiveness and safety of tenofovir in 302 NUC-naive patients with chronic hepatitis B: a multicenter European study in clinical practice

✍ P. Lampertico; R. Soffredini; M. Viganò; C. Yurdaydin; R. Idilman; G.V. Papatheo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB